93p -1.0 -1.1%
Last Trade - 02/12/20
| Market Cap | £79.1m |
| Enterprise Value | £80.7m |
| Revenue | £27.7m |
| Position in Universe | 1047th / 1802 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Dec | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020E | 2021E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 7.19 | 9.08 | 14.3 | 16.1 | 18.8 | 20.2 | 30.2 | 41.9 | +23.0% | ||
| +109.7 | +317.9 | +30.8 | ||||||||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2020
|
31st Dec 2021
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Venture Life Group plc is an international consumer self-care company. The Company focuses on developing, manufacturing and commercializing products for the ageing population. Its segments include Brands, which includes sales of branded healthcare and cosmetics products direct to retailers and under distribution agreements, and Manufacturing, which includes sales of products and services under contract development and manufacturing agreements. Its product range includes the UltraDEX and Dentyl oral care range, which is primarily sold in the United Kingdom through the pharmacy and grocery retailers. Its product range also includes food supplements for lowering cholesterol and maintaining brain function, dermo-cosmetics for addressing the signs of ageing and medical devices for conditions, such as hemorrhoids, minor aches and pains, and women's intimate health issues. It also provides development and manufacturing services to other companies in the healthcare and skincare sectors.
| Last Annual | December 31st, 2019 |
| Last Interim | June 30th, 2020 |
| Incorporated | December 12, 2005 |
| Public Since | March 28, 2014 |
| No. of Shareholders: | n/a |
| No. of Employees: | 109 |
| Sector | Healthcare |
| Industry | Pharmaceuticals |
| Index | FTSE Aim All Share , |
| Exchange | London Stock Exchange (AIM) |
| Shares in Issue | 84,141,962 |
| Free Float | (0.0%) |
| Eligible for |
ISAs
SIPPs
|
| Address | Unit 12 The Courtyard Eastern Road, BRACKNELL, RG12 2XB, United Kingdom |
| Web | http://www.venture-life.com/ |
| Phone | +44 1344 578004 |
| Contact | () |
| Auditors | Grant Thornton UK LLP |
As of 02/12/20, shares in Venture Life are trading at 93p, giving the company a market capitalisation of £79.1m. This share price information is delayed by 15 minutes.
Shares in Venture Life are currently trading at 93p and the price has moved by 0.228k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Venture Life price has moved by 0.268k% over the past year.
Of the analysts with advisory recommendations for Venture Life, there are there are currently 0 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Venture Life is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Venture Life is scheduled to issue upcoming financial results on the following dates:
Venture Life does not currently pay a dividend.
Venture Life does not currently pay a dividend.
Venture Life does not currently pay a dividend.
To buy shares in Venture Life you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Venture Life are currently trading at 93p, giving the company a market capitalisation of £79.1m.
Here are the trading details for Venture Life:
Based on an overall assessment of its quality, value and momentum, Venture Life is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Shares in Venture Life are currently priced at 93p. At that level they are trading at 10.49% discount to the analyst consensus target price of 103.90.
Analysts covering Venture Life currently have a consensus Earnings Per Share (EPS) forecast of 0.04873 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Venture Life. Over the past six months, the relative strength of its shares against the market has been 42.35%. At the current price of 93p, shares in Venture Life are trading at 27.88% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Venture Life PE ratio based on its reported earnings over the past 12 months is 27.74. The shares are currently trading at 93p.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Venture Life's management team is headed by:
Here are the top five shareholders of Venture Life based on the size of their shareholding:
